Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary hyperoxaluria type 1: still challenging!

Pierre Cochat1, Aurélia Liutkus, Sonia Fargue

  • 1Centre de Référence des Maladies Rénales Héréditaires, Hôpital Edouard-Herriot, Lyon, France. pierre.cochat@chu-lyon.fr

Pediatric Nephrology (Berlin, Germany)
|July 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endogenous oxalate synthesis in mouse models of metabolic dysfunction-associated steatotic liver disease.

American journal of physiology. Renal physiology·2026
Same author

Navigating the methodological, ethical, and operational challenges of Trials within Cohorts (TwiCs): insights from a French pediatric research-based cohort.

Journal of clinical epidemiology·2026
Same author

Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases.

EBioMedicine·2026
Same author

Intraperitoneal pressure measurements in children on peritoneal dialysis: a review and European practice survey.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD.

Clinical kidney journal·2025
Same author

Efficacy of Calcineurin Inhibition in Children With Steroid-Resistant Nephrotic Syndrome.

Kidney international reports·2025
Same journal

Correlation between urinary soluble CD163 and endocapillary proliferation and fibrinoid necrosis in IgA vasculitis with nephritis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

SGLT2i, anti-endothelin A and double endothelin and angiotensin inhibitors: a new future for chronic kidney disease in children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

The role of urinary trehalase levels in the early diagnosis of acute kidney injury in dehydrated children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Neuron-specific enolase and brain-derived neurotrophic factor as developmental neurovascular markers in chronic kidney disease and kidney transplantation.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Chronic hyponatraemia with a reset osmostat: when abnormal is normal.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis.

Pediatric nephrology (Berlin, Germany)·2026
See all related articles

Primary hyperoxaluria type 1 is a genetic disorder causing oxalate buildup and kidney damage. Early diagnosis and treatment, including hydration and pyridoxine, are crucial for managing kidney function and preventing systemic oxalosis.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Nephrology

Background:

  • Primary hyperoxaluria type 1 (PH1) is an inherited metabolic disease.
  • It stems from a deficiency in alanine: glyoxylate aminotransferase (AGT), a liver enzyme.
  • This deficiency leads to excessive oxalate synthesis and deposition in kidneys.

Purpose of the Study:

  • To outline the pathophysiology of PH1.
  • To discuss diagnostic approaches for PH1.
  • To review current and potential treatment strategies for PH1.

Main Methods:

  • Diagnosis relies on clinical presentation, imaging, biochemical tests (urinary oxalate/glycolate), DNA analysis, and AGT activity assays.
  • Conservative management includes hydration, citrate/phosphate supplementation, and pyridoxine for responsive patients.

Related Experiment Videos

  • Interventional treatments involve extracorporeal shock-wave lithotripsy, JJ stent insertion, liver transplantation, and aggressive dialysis.

    • Main Results:

    • Delayed diagnosis is common, impacting patient outcomes.
    • Early conservative measures can preserve renal function.
    • Liver transplantation is a definitive treatment to correct the enzyme defect.
    • Dialysis is essential for end-stage renal disease to manage oxalate accumulation.

    Conclusions:

    • PH1 requires timely diagnosis and multidisciplinary management.
    • Liver transplantation, ideally before systemic oxalosis, offers the best prognosis.
    • Optimizing dialysis and minimizing time on dialysis improve survival and quality of life in advanced disease.